mci 9038 has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Y; Ding, Q; Feng, C; Feng, Z; Li, S; Liu, F; Liu, X; Liu, Y; Qiu, Y; Ren, X; Tian, C; Wei, Y; Ying, H; Yu, W; Zhao, Y; Zhou, T | 1 |
| Copple, BL; Cui, W; Kassel, KM; Luyendyk, JP; Sullivan, BP | 1 |
2 other study(ies) available for mci 9038 and Liver Steatosis
| Article | Year |
|---|---|
MRG15 orchestrates rhythmic epigenomic remodelling and controls hepatic lipid metabolism.
Topics: Animals; Arginine; Cell Line; Chromosomal Proteins, Non-Histone; Circadian Rhythm; Epigenesis, Genetic; Epigenomics; Fatty Liver; Glucose Tolerance Test; Histones; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Pipecolic Acids; Receptors, Cytoplasmic and Nuclear; RNA Polymerase II; Sulfonamides; Trans-Activators | 2020 |
Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
Topics: Animals; Arginine; Chemokine CCL2; Chemokine CXCL2; Collagen; Diet; Fatty Liver; Feeding Behavior; Gene Expression Regulation; Inflammation; Intercellular Adhesion Molecule-1; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pipecolic Acids; Receptors, LDL; RNA, Messenger; Sulfonamides; Thrombin; Weight Gain | 2012 |